VDJ
About:
VDJ is an antibody drug research and development enterprise.
Website: https://www.vdjbio.com/
Top Investors: TusStar, Lotus Lake Ventures, KMT Technology, Hongcheng Capital, Huadian Investment
Description:
VDJ is an antibody affinity enhancement platform that simulates the maturation mechanism of human antibodies and is specialized in autoimmune diseases. Their products include IL-6R antibodies and CTLA-4-Ig. They serve markets.
Total Funding Amount:
56M CNY
Headquarters Location:
Haidian, Beijing, China
Founded Date:
2011-07-20
Founders:
Ziqiang Li
Number of Employees:
11-50
Last Funding Date:
2023-06-06
IPO Status:
Private
Industries:
© 2025 bioDAO.ai